MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Anti-Parkinsonian effects of Globimetula cupulata leaf extract and its underlying mechanisms in 6-hydroxydopamine-lesioned rat model

    A. Hamadjida, R. Ayissi Mbomo, S. Minko, F. Ntchapda, J. Mingoas Kilekoung (BERTOUA, Cameroon)

    Objective: To evaluate the neuroprotective effects of Globimetula cupulata in a rat model of Parkinson Disease (PD) induced by 6-hydroxydopamine (6-OHDA) injection in the striatum,…
  • 2025 International Congress

    Gender Based Differences in Impulse Control Disorders within Parkinson’s Disease

    N. David, M. Steinberg, L. Higginbotham, R. Tripathi (Atlanta, USA)

    Objective: Analyze associations between gender, dopamine agonists, and levodopa doses in Parkinson’s Disease (PD) patients with Impulse control disorder (ICD). Background: ICDs, which include compulsive…
  • 2025 International Congress

    Factors contributing to balance discordance and its impact on fear of falling avoidance behavior in Parkinson’s disease

    S. Conklin, D. Peterson, A. Hooyman, J. Longhurst (Saint Louis, USA)

    Objective: To identify cognitive and psychological factors contributing to balance discordance in people with Parkinson's disease (PwPD) and examine how it is associated with fear…
  • 2025 International Congress

    A Qualitative Approach to Extract Diagnostic Patterns of Cognitive Impairment in Parkinson’s Disease

    A. Eubank, A. Thatikala, M. Garza, H. Khan, T. Virmani, R. Dhall, J. Talburt, L. Larson-Prior, F. Prior (Little Rock, USA)

    Objective: This study distilled patterns of patient performance recognized by clinical professionals in people with Parkinson’s disease (PD) and cognitive impairment on the Montreal Cognitive…
  • 2025 International Congress

    Superior cluneal neuralgia in Parkinson’s disease: frequency and clinical features.

    M. Mihara, Y. Kajiyama, A. Saito, R. Satake, Y. Kutoku (Kurashiki, Japan)

    Objective: We investigated the frequency and clinical characteristics of superior cluneal neuralgia (SCN) in patients with Parkinson's disease (PD). Background: The superior cluneal nerve is…
  • 2025 International Congress

    Turkish Validity and Reliability Study of the Gastrointestinal Dysfunction Scale for Parkinson’s Disease

    S. Irmak, H. Omercikoglu, D. Gunal (İstanbul, Turkey)

    Objective: The aim of this study is to make a Turkish adaptation of the "Gastrointestinal Dysfunction Scale for PD (GIDS-PD)"and detect gastrointestinal symptoms at an…
  • 2025 International Congress

    The sphingolipid Lyso-Gb3, a biomarker for the lysosomal storage disorder Fabry Disease, is significantly elevated in blood from patients with Parkinson’s Disease

    C. Beetz, C. Cozma, M. Iurascu, S. Fischer, S. Oppermann, K. Kandaswamy, P. Bauer (Rostock, Germany)

    Objective: To better understand lysosomal dysfunction in Parkinson’s Disease. Background: Lysosomal dysfunction and α-synuclein accumulation play central roles in Parkinson’s Disease. They are interconnected by…
  • 2025 International Congress

    Facilitators and Barriers to Exercise Program Implementation in Parkinson’s Disease Rehabilitation: A Comprehensive Review Using the Consolidated Framework for Implementation Research

    M. M. Elsayed, N. Bekhit, F. Sakr, A. Hafez, O. Awadalla, M. Mohamed, A. Nagah (Mansoura, Egypt)

    Objective: To systematically identify and evaluate the facilitators and barriers influencing the implementation of exercise programs in Parkinson’s disease (PD) rehabilitation using the Consolidated Framework…
  • 2025 International Congress

    Clinical Profile and 18F -Fluorodopa Positron Emission Tomography (18F -DOPA PET) Findings in a Movement Disorder Clinic Patient Cohort

    S. Yellaturi, M. Prabhu, A. Behera, S. Pandey (Faridabad, India)

    Objective: This study aimed to evaluate the utility of 18F -DOPA PET in patients with diagnostic uncertainty at our movement disorder clinic in India. Background:…
  • 2025 International Congress

    Trail Making Task in people with isolated REM sleep behaviour disorder

    H. Chohan, T. Periñán, S. Waters, L. Pérez-Carbonell, G. Leschziner, J. Bestwick, A. Schrag, A. Noyce, C. Simonet (London, United Kingdom)

    Objective: This study aimed to evaluate online remote executive function in individuals with isolated polysomnography (PSG)-confirmed REM sleep behaviour disorder (iRBD). Background: The Trail Making…
  • « Previous Page
  • 1
  • …
  • 163
  • 164
  • 165
  • 166
  • 167
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28953 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley